Allogeneic Transplant in ELANE and MEFV Mutation Positive Severe Cyclic Neutropenia: Review of Prognostic Factors for Secondary Severe Events

<div>Engrafting bone marrow with trilineage hematopoiesis and decreased cellularity compared to previous marrow (30% versus 80%). (a) Bone marrow aspirate low power (10x), (b) bone marrow aspirate high power (60x), (c) bone marrow core biopsy (40x), and (d) bone marrow core biopsy (100x).</div>

Case Reports in Hematology

fig2

Figure 2

Figure 2: Allogeneic Transplant in ELANE and MEFV Mutation Positive Severe Cyclic Neutropenia: Review of Prognostic Factors for Secondary Severe Events 

Figure 2 | Allogeneic Transplant in ELANE and MEFV Mutation Positive Severe Cyclic Neutropenia: Review of Prognostic Factors for Secondary Severe Events 